Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

Extracellular vesicles from symbiotic vaginal lactobacilli inhibit HIV-1 infection of human tissues.

Ñahui Palomino RA, Vanpouille C, Laghi L, Parolin C, Melikov K, Backlund P, Vitali B, Margolis L.

Nat Commun. 2019 Dec 11;10(1):5656. doi: 10.1038/s41467-019-13468-9.

2.

Computer Vision Approach for the Determination of Microbial Concentration and Growth Kinetics Using a Low Cost Sensor System.

Grossi M, Parolin C, Vitali B, Riccò B.

Sensors (Basel). 2019 Dec 5;19(24). pii: E5367. doi: 10.3390/s19245367.

3.

Diversity of vaginal microbiome and metabolome during genital infections.

Ceccarani C, Foschi C, Parolin C, D'Antuono A, Gaspari V, Consolandi C, Laghi L, Camboni T, Vitali B, Severgnini M, Marangoni A.

Sci Rep. 2019 Oct 1;9(1):14095. doi: 10.1038/s41598-019-50410-x.

4.

In-vitro effect of vaginal lactobacilli against group B Streptococcus.

Marziali G, Foschi C, Parolin C, Vitali B, Marangoni A.

Microb Pathog. 2019 Nov;136:103692. doi: 10.1016/j.micpath.2019.103692. Epub 2019 Aug 21.

PMID:
31445119
5.

Liposomes containing biosurfactants isolated from Lactobacillus gasseri exert antibiofilm activity against methicillin resistant Staphylococcus aureus strains.

Giordani B, Costantini PE, Fedi S, Cappelletti M, Abruzzo A, Parolin C, Foschi C, Frisco G, Calonghi N, Cerchiara T, Bigucci F, Luppi B, Vitali B.

Eur J Pharm Biopharm. 2019 Jun;139:246-252. doi: 10.1016/j.ejpb.2019.04.011. Epub 2019 Apr 13.

PMID:
30991089
6.

Freeze-Dried Matrices Based on Polyanion Polymers for Chlorhexidine Local Release in the Buccal and Vaginal Cavities.

Giordani B, Abruzzo A, Musazzi UM, Cilurzo F, Nicoletta FP, Dalena F, Parolin C, Vitali B, Cerchiara T, Luppi B, Bigucci F.

J Pharm Sci. 2019 Jul;108(7):2447-2457. doi: 10.1016/j.xphs.2019.02.026. Epub 2019 Mar 7.

PMID:
30853513
7.

Univariate Statistical Analysis as a Guide to ¹H-NMR Spectra Signal Assignment by Visual Inspection.

Zhu C, Vitali B, Donders G, Parolin C, Li Y, Laghi L.

Metabolites. 2019 Jan 15;9(1). pii: E15. doi: 10.3390/metabo9010015.

8.

Use of Lactobacillus crispatus to produce a probiotic cheese as potential gender food for preventing gynaecological infections.

Patrignani F, Siroli L, Parolin C, Serrazanetti DI, Vitali B, Lanciotti R.

PLoS One. 2019 Jan 9;14(1):e0208906. doi: 10.1371/journal.pone.0208906. eCollection 2019.

9.

Lactobacillus crispatus BC5 Interferes With Chlamydia trachomatis Infectivity Through Integrin Modulation in Cervical Cells.

Parolin C, Frisco G, Foschi C, Giordani B, Salvo M, Vitali B, Marangoni A, Calonghi N.

Front Microbiol. 2018 Nov 6;9:2630. doi: 10.3389/fmicb.2018.02630. eCollection 2018.

10.

Vaginal Bifidobacterium breve for preventing urogenital infections: Development of delayed release mucoadhesive oral tablets.

Giordani B, Melgoza LM, Parolin C, Foschi C, Marangoni A, Abruzzo A, Dalena F, Cerchiara T, Bigucci F, Luppi B, Vitali B.

Int J Pharm. 2018 Oct 25;550(1-2):455-462. doi: 10.1016/j.ijpharm.2018.09.003. Epub 2018 Sep 5.

PMID:
30195082
11.

Insights Into Vaginal Bacterial Communities and Metabolic Profiles of Chlamydia trachomatis Infection: Positioning Between Eubiosis and Dysbiosis.

Parolin C, Foschi C, Laghi L, Zhu C, Banzola N, Gaspari V, D'Antuono A, Giordani B, Severgnini M, Consolandi C, Salvo M, Cevenini R, Vitali B, Marangoni A.

Front Microbiol. 2018 Mar 28;9:600. doi: 10.3389/fmicb.2018.00600. eCollection 2018.

12.

Vaginal Lactobacilli Reduce Neisseria gonorrhoeae Viability through Multiple Strategies: An in Vitro Study.

Foschi C, Salvo M, Cevenini R, Parolin C, Vitali B, Marangoni A.

Front Cell Infect Microbiol. 2017 Dec 6;7:502. doi: 10.3389/fcimb.2017.00502. eCollection 2017.

13.

In vitro activity of Spirulina platensis water extract against different Candida species isolated from vulvo-vaginal candidiasis cases.

Marangoni A, Foschi C, Micucci M, Nahui Palomino RA, Gallina Toschi T, Vitali B, Camarda L, Mandrioli M, De Giorgio M, Aldini R, Corazza I, Chiarini A, Cevenini R, Budriesi R.

PLoS One. 2017 Nov 30;12(11):e0188567. doi: 10.1371/journal.pone.0188567. eCollection 2017.

14.

Efficacy and Safety of a Multistrain Probiotic Formulation Depends from Manufacturing.

Trinchieri V, Laghi L, Vitali B, Parolin C, Giusti I, Capobianco D, Mastromarino P, De Simone C.

Front Immunol. 2017 Nov 6;8:1474. doi: 10.3389/fimmu.2017.01474. eCollection 2017.

15.

Novel mixed vesicles containing lactobacilli biosurfactant for vaginal delivery of an anti-Candida agent.

Abruzzo A, Giordani B, Parolin C, Vitali B, Protti M, Mercolini L, Cappelletti M, Fedi S, Bigucci F, Cerchiara T, Luppi B.

Eur J Pharm Sci. 2018 Jan 15;112:95-101. doi: 10.1016/j.ejps.2017.11.012. Epub 2017 Nov 11.

PMID:
29138104
16.

Investigation on the Effects of Antimicrobial imidazo[2,1-b]thiazole Derivatives on the Genitourinary Microflora.

Morigi R, Vitali B, Prata C, Palomino RAN, Graziadio A, Locatelli A, Rambaldi M, Leoni A.

Med Chem. 2018;14(3):311-319. doi: 10.2174/1573406413666171010110819.

PMID:
29032761
17.

Role of Molecular Biology in Diagnosis and Characterization of Vulvo-Vaginitis in Clinical Practice.

Donders GGG, Ravel J, Vitali B, Netea MG, Salumets A, Unemo M.

Gynecol Obstet Invest. 2017;82(6):607-616. doi: 10.1159/000478982. Epub 2017 Oct 10.

PMID:
29017160
18.

Metabolic Variability of a Multispecies Probiotic Preparation Impacts on the Anti-inflammatory Activity.

Biagioli M, Laghi L, Carino A, Cipriani S, Distrutti E, Marchianò S, Parolin C, Scarpelli P, Vitali B, Fiorucci S.

Front Pharmacol. 2017 Jul 28;8:505. doi: 10.3389/fphar.2017.00505. eCollection 2017.

19.

Design and validation of a DNA-microarray for phylogenetic analysis of bacterial communities in different oral samples and dental implants.

Parolin C, Giordani B, Ñahui Palomino RA, Biagi E, Severgnini M, Consolandi C, Caredda G, Storelli S, Strohmenger L, Vitali B.

Sci Rep. 2017 Jul 24;7(1):6280. doi: 10.1038/s41598-017-06743-6.

20.

Interaction of vaginal Lactobacillus strains with HeLa cells plasma membrane.

Calonghi N, Parolin C, Sartor G, Verardi L, Giordani B, Frisco G, Marangoni A, Vitali B.

Benef Microbes. 2017 Aug 24;8(4):625-633. doi: 10.3920/BM2016.0212. Epub 2017 Jun 16.

PMID:
28618863
21.

Vaginal Lactobacillus Inhibits HIV-1 Replication in Human Tissues Ex Vivo.

Ñahui Palomino RA, Zicari S, Vanpouille C, Vitali B, Margolis L.

Front Microbiol. 2017 May 19;8:906. doi: 10.3389/fmicb.2017.00906. eCollection 2017.

22.

Determination of Antibacterial and Technological Properties of Vaginal Lactobacilli for Their Potential Application in Dairy Products.

Siroli L, Patrignani F, Serrazanetti DI, Parolin C, Ñahui Palomino RA, Vitali B, Lanciotti R.

Front Microbiol. 2017 Feb 7;8:166. doi: 10.3389/fmicb.2017.00166. eCollection 2017.

23.

Novel approaches for the taxonomic and metabolic characterization of lactobacilli: Integration of 16S rRNA gene sequencing with MALDI-TOF MS and 1H-NMR.

Foschi C, Laghi L, Parolin C, Giordani B, Compri M, Cevenini R, Marangoni A, Vitali B.

PLoS One. 2017 Feb 16;12(2):e0172483. doi: 10.1371/journal.pone.0172483. eCollection 2017.

24.

Spanish Broom (Spartium junceum L.) fibers impregnated with vancomycin-loaded chitosan nanoparticles as new antibacterial wound dressing: Preparation, characterization and antibacterial activity.

Cerchiara T, Abruzzo A, Ñahui Palomino RA, Vitali B, De Rose R, Chidichimo G, Ceseracciu L, Athanassiou A, Saladini B, Dalena F, Bigucci F, Luppi B.

Eur J Pharm Sci. 2017 Mar 1;99:105-112. doi: 10.1016/j.ejps.2016.11.028. Epub 2016 Dec 5.

PMID:
27931851
25.

Lactobacillus crispatus inhibits the infectivity of Chlamydia trachomatis elementary bodies, in vitro study.

Nardini P, Ñahui Palomino RA, Parolin C, Laghi L, Foschi C, Cevenini R, Vitali B, Marangoni A.

Sci Rep. 2016 Jun 29;6:29024. doi: 10.1038/srep29024.

26.

Microparticles based on chitosan/carboxymethylcellulose polyelectrolyte complexes for colon delivery of vancomycin.

Cerchiara T, Abruzzo A, Parolin C, Vitali B, Bigucci F, Gallucci MC, Nicoletta FP, Luppi B.

Carbohydr Polym. 2016 Jun 5;143:124-30. doi: 10.1016/j.carbpol.2016.02.020. Epub 2016 Feb 9.

PMID:
27083351
27.

Association of Lactobacillus crispatus with fructo-oligosaccharides and ascorbic acid in hydroxypropyl methylcellulose vaginal insert.

Vitali B, Abruzzo A, Parolin C, Palomino RA, Dalena F, Bigucci F, Cerchiara T, Luppi B.

Carbohydr Polym. 2016 Jan 20;136:1161-9. doi: 10.1016/j.carbpol.2015.10.035. Epub 2015 Oct 22.

PMID:
26572459
28.

Vaginal microbiome and metabolome highlight specific signatures of bacterial vaginosis.

Vitali B, Cruciani F, Picone G, Parolin C, Donders G, Laghi L.

Eur J Clin Microbiol Infect Dis. 2015 Dec;34(12):2367-76. doi: 10.1007/s10096-015-2490-y. Epub 2015 Sep 18.

PMID:
26385347
29.

Isolation of Vaginal Lactobacilli and Characterization of Anti-Candida Activity.

Parolin C, Marangoni A, Laghi L, Foschi C, Ñahui Palomino RA, Calonghi N, Cevenini R, Vitali B.

PLoS One. 2015 Jun 22;10(6):e0131220. doi: 10.1371/journal.pone.0131220. eCollection 2015.

30.

Chitosan based micro- and nanoparticles for colon-targeted delivery of vancomycin prepared by alternative processing methods.

Cerchiara T, Abruzzo A, di Cagno M, Bigucci F, Bauer-Brandl A, Parolin C, Vitali B, Gallucci MC, Luppi B.

Eur J Pharm Biopharm. 2015 May;92:112-9. doi: 10.1016/j.ejpb.2015.03.004. Epub 2015 Mar 11.

PMID:
25769679
31.

Development of a microarray-based tool to characterize vaginal bacterial fluctuations and application to a novel antibiotic treatment for bacterial vaginosis.

Cruciani F, Biagi E, Severgnini M, Consolandi C, Calanni F, Donders G, Brigidi P, Vitali B.

Antimicrob Agents Chemother. 2015 May;59(5):2825-34. doi: 10.1128/AAC.00225-15. Epub 2015 Mar 2.

32.

Vaginal inserts based on chitosan and carboxymethylcellulose complexes for local delivery of chlorhexidine: preparation, characterization and antimicrobial activity.

Bigucci F, Abruzzo A, Vitali B, Saladini B, Cerchiara T, Gallucci MC, Luppi B.

Int J Pharm. 2015 Jan 30;478(2):456-63. doi: 10.1016/j.ijpharm.2014.12.008. Epub 2014 Dec 6.

PMID:
25490184
33.

Rifaximin modulates the vaginal microbiome and metabolome in women affected by bacterial vaginosis.

Laghi L, Picone G, Cruciani F, Brigidi P, Calanni F, Donders G, Capozzi F, Vitali B.

Antimicrob Agents Chemother. 2014 Jun;58(6):3411-20. doi: 10.1128/AAC.02469-14. Epub 2014 Apr 7.

34.

Bacterial vaginosis: a review on clinical trials with probiotics.

Mastromarino P, Vitali B, Mosca L.

New Microbiol. 2013 Jul;36(3):229-38. Epub 2013 Jun 30. Review.

35.

Proteome profiles of vaginal fluids from women affected by bacterial vaginosis and healthy controls: outcomes of rifaximin treatment.

Cruciani F, Wasinger V, Turroni S, Calanni F, Donders G, Brigidi P, Vitali B.

J Antimicrob Chemother. 2013 Nov;68(11):2648-59. doi: 10.1093/jac/dkt244. Epub 2013 Jun 24.

PMID:
23798671
36.

Chitosan/alginate complexes for vaginal delivery of chlorhexidine digluconate.

Abruzzo A, Bigucci F, Cerchiara T, Saladini B, Gallucci MC, Cruciani F, Vitali B, Luppi B.

Carbohydr Polym. 2013 Jan 16;91(2):651-8. doi: 10.1016/j.carbpol.2012.08.074. Epub 2012 Aug 29.

PMID:
23121960
37.

Dietary supplementation with probiotics during late pregnancy: outcome on vaginal microbiota and cytokine secretion.

Vitali B, Cruciani F, Baldassarre ME, Capursi T, Spisni E, Valerii MC, Candela M, Turroni S, Brigidi P.

BMC Microbiol. 2012 Oct 18;12:236. doi: 10.1186/1471-2180-12-236.

38.
39.

Efficacy of rifaximin vaginal tablets in treatment of bacterial vaginosis: a molecular characterization of the vaginal microbiota.

Cruciani F, Brigidi P, Calanni F, Lauro V, Tacchi R, Donders G, Peters K, Guaschino S, Vitali B.

Antimicrob Agents Chemother. 2012 Aug;56(8):4062-70. doi: 10.1128/AAC.00061-12. Epub 2012 May 14.

40.

An in vitro evaluation of the effect of probiotics and prebiotics on the metabolic profile of human microbiota.

Vitali B, Ndagijimana M, Maccaferri S, Biagi E, Guerzoni ME, Brigidi P.

Anaerobe. 2012 Aug;18(4):386-91. doi: 10.1016/j.anaerobe.2012.04.014. Epub 2012 May 8.

PMID:
22579985
41.

Novel probiotic candidates for humans isolated from raw fruits and vegetables.

Vitali B, Minervini G, Rizzello CG, Spisni E, Maccaferri S, Brigidi P, Gobbetti M, Di Cagno R.

Food Microbiol. 2012 Aug;31(1):116-25. doi: 10.1016/j.fm.2011.12.027. Epub 2012 Jan 18.

PMID:
22475949
42.

An evolutionary recent neuroepithelial cell adhesion function of huntingtin implicates ADAM10-Ncadherin.

Lo Sardo V, Zuccato C, Gaudenzi G, Vitali B, Ramos C, Tartari M, Myre MA, Walker JA, Pistocchi A, Conti L, Valenza M, Drung B, Schmidt B, Gusella J, Zeitlin S, Cotelli F, Cattaneo E.

Nat Neurosci. 2012 May;15(5):713-21. doi: 10.1038/nn.3080.

PMID:
22466506
43.

Correlation of Atopobium vaginae Amount With Bacterial Vaginosis Markers.

Marconi C, Cruciani F, Vitali B, Donders GG.

J Low Genit Tract Dis. 2012 Apr;16(2):127-32. doi: 10.1097/LGT.0b013e31823c79c4.

PMID:
22371042
44.

Brain-derived neurotrophic factor in patients with Huntington's disease.

Zuccato C, Marullo M, Vitali B, Tarditi A, Mariotti C, Valenza M, Lahiri N, Wild EJ, Sassone J, Ciammola A, Bachoud-Lèvi AC, Tabrizi SJ, Di Donato S, Cattaneo E.

PLoS One. 2011;6(8):e22966. doi: 10.1371/journal.pone.0022966. Epub 2011 Aug 12.

45.

Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system.

Maccaferri S, Vitali B, Klinder A, Kolida S, Ndagijimana M, Laghi L, Calanni F, Brigidi P, Gibson GR, Costabile A.

J Antimicrob Chemother. 2010 Dec;65(12):2556-65. doi: 10.1093/jac/dkq345. Epub 2010 Sep 18.

PMID:
20852272
46.

Oxalate-degrading activity in Bifidobacterium animalis subsp. lactis: impact of acidic conditions on the transcriptional levels of the oxalyl coenzyme A (CoA) decarboxylase and formyl-CoA transferase genes.

Turroni S, Bendazzoli C, Dipalo SC, Candela M, Vitali B, Gotti R, Brigidi P.

Appl Environ Microbiol. 2010 Aug;76(16):5609-20. doi: 10.1128/AEM.00844-10. Epub 2010 Jul 2.

47.

Development of microparticulate systems for intestinal delivery of Lactobacillus acidophilus and Bifidobacterium lactis.

Albertini B, Vitali B, Passerini N, Cruciani F, Di Sabatino M, Rodriguez L, Brigidi P.

Eur J Pharm Sci. 2010 Jul 11;40(4):359-66. doi: 10.1016/j.ejps.2010.04.011. Epub 2010 Apr 24.

PMID:
20420903
48.

High taxonomic level fingerprint of the human intestinal microbiota by ligase detection reaction--universal array approach.

Candela M, Consolandi C, Severgnini M, Biagi E, Castiglioni B, Vitali B, De Bellis G, Brigidi P.

BMC Microbiol. 2010 Apr 19;10:116. doi: 10.1186/1471-2180-10-116.

49.

Impact of a synbiotic food on the gut microbial ecology and metabolic profiles.

Vitali B, Ndagijimana M, Cruciani F, Carnevali P, Candela M, Guerzoni ME, Brigidi P.

BMC Microbiol. 2010 Jan 7;10:4. doi: 10.1186/1471-2180-10-4.

50.

Antibiotics and probiotics in chronic pouchitis: a comparative proteomic approach.

Turroni S, Vitali B, Candela M, Gionchetti P, Rizzello F, Campieri M, Brigidi P.

World J Gastroenterol. 2010 Jan 7;16(1):30-41.

Supplemental Content

Loading ...
Support Center